Ex Parte KENT et al - Page 6


                   Appeal No.  2001-0762                                                                 Page 6                    
                   Application No.  08/343,585                                                                                     
                   binding, which is required to provide the protein with it’s “honorary” enzymatic                                
                   activity.  Nevertheless, the examiner asserts (id.)”                                                            
                          a person of ordinary skill in the art would reasonably expect that the                                   
                          all-D Ni2+ rubredoxin analog would exhibit the same hydrogenase-                                         
                          like activity discussed for the all-L Ni2+ rubredoxin in Zawadzke et                                     
                          al. (citing Saint-Martin …) as a result of the binding of Ni2+ to the                                    
                          coordinating site in the same manner in either all-D or all-L                                            
                          rubredoxin.                                                                                              
                          However, as appellants point out, the facts in evidence dispute the                                      
                   examiner’s conclusion.  According to appellants (Brief, page 8), Saint-Martin                                   
                   state “‘[a]t present it is difficult to establish a complete mechanism for hydrogen                             
                   activation by the modified rubredoxins.”  With regard to the rubredoxin isolate                                 
                   used by Zawadzke appellants argue that Saint-Martin state:                                                      
                          This rubredoxin has the peculiarity of having the shortest amino                                         
                          acid polypeptide chain (45 amino acids instead of the 53 of the                                          
                          other two) but has one more cysteine (5 cysteine residues instead                                        
                          of 4) … These differences may be significant in the respective                                           
                          activities observed, but further experiments are necessary to                                            
                          assess the implication of these differences in the mechanism of                                          
                          activation of the hydrogen molecule by the modified Ni-rubredoxins.                                      
                          To support prima facie case of obviousness, the prior art relied upon must                               
                   provide a person of ordinary skill in the art with a reasonable expectation of                                  
                   success.  In re Vaeck, 947 F.2d 488, 493, 20 USPQ2d 1438, 1442 (Fed. Cir.                                       
                   1991).  Based on the evidence of record, and in contrast to the examiner’s                                      
                   position, we are compelled to agree with appellants (Brief, page 9) that one of                                 
                   ordinary skill in the art at the time the invention was made would not have                                     
                   believed that the changes between the native and analog rubredoxins were                                        
                   minor with respect to its hydrogenase activity, or that it could be reasonably                                  
                   expected that Zawadzke’s modified rubredoxin would have had the hydrogenase                                     






Page:  Previous  1  2  3  4  5  6  7  8  Next 

Last modified: November 3, 2007